Artivion vs Atricure
Atricure is the larger business, with $535m of revenue in fiscal 2025 against $441m for Artivion (1.2 times as much). Atricure grew faster (14.9% against 13.6%). Artivion kept more of each dollar of sales as profit: a net margin of 2.2% against -2.1%.
| Latest fiscal year | ArtivionAORT, 2025 | AtricureATRC, 2025 |
|---|---|---|
| Revenue | $441m | $535m |
| Revenue growth | 13.6% | 14.9% |
| Net income | $9.8m | −$11.4m |
| Operating margin | 7.6% | — |
| Net margin | 2.2% | -2.1% |
| Return on equity | 2.7% | -2.4% |
| Free cash flow | $839,000 | $48.3m |
| Cash | $64.9m | $167m |
| Total debt | $220m | $61.9m |
| Debt to equity | 49.1% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 1,800 | 1,350 |
| Market value | $1.15bn | $3.07bn |
| Price vs our value range | — | — |
| Moat score | 39 (Weak) | 39 (Weak) |
| Insider trades, 12 months | 0 buys, 64 sales | 0 buys, 17 sales |